CollPlant Biotechnologies (CLGN) Inventory (2018 - 2025)

CollPlant Biotechnologies' Inventory history spans 8 years, with the latest figure at $573000.0 for Q4 2025.

  • For Q4 2025, Inventory rose 30.23% year-over-year to $573000.0; the TTM value through Dec 2025 reached $573000.0, up 30.23%, while the annual FY2025 figure was $573000.0, 30.23% up from the prior year.
  • Inventory reached $573000.0 in Q4 2025 per CLGN's latest filing, up from $440000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.4 million in Q4 2022 to a low of $440000.0 in Q4 2024.
  • Average Inventory over 5 years is $847600.0, with a median of $714000.0 recorded in 2023.
  • Peak YoY movement for Inventory: surged 32.28% in 2022, then crashed 50.07% in 2023.
  • A 5-year view of Inventory shows it stood at $1.1 million in 2021, then soared by 32.28% to $1.4 million in 2022, then plummeted by 50.07% to $714000.0 in 2023, then plummeted by 38.38% to $440000.0 in 2024, then skyrocketed by 30.23% to $573000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Inventory are $573000.0 (Q4 2025), $440000.0 (Q4 2024), and $714000.0 (Q4 2023).